

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of erythrocyte differentiation (GO:0045647) | 6.68891217 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.27746029 |
| 3 | positive regulation of B cell differentiation (GO:0045579) | 5.33875310 |
| 4 | definitive hemopoiesis (GO:0060216) | 4.97830448 |
| 5 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.82105920 |
| 6 | positive regulation of granulocyte differentiation (GO:0030854) | 4.81601335 |
| 7 | response to peptidoglycan (GO:0032494) | 4.67919516 |
| 8 | cellular extravasation (GO:0045123) | 4.60180354 |
| 9 | response to muramyl dipeptide (GO:0032495) | 4.59841981 |
| 10 | regulation of gamma-delta T cell activation (GO:0046643) | 4.59535226 |
| 11 | poly(A)+ mRNA export from nucleus (GO:0016973) | 4.51994517 |
| 12 | B cell receptor signaling pathway (GO:0050853) | 4.48440826 |
| 13 | negative regulation of granulocyte differentiation (GO:0030853) | 4.39427773 |
| 14 | neutrophil activation involved in immune response (GO:0002283) | 4.38925937 |
| 15 | mannose metabolic process (GO:0006013) | 4.30070140 |
| 16 | regulation of B cell differentiation (GO:0045577) | 4.24384192 |
| 17 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.22567994 |
| 18 | regulation of granulocyte differentiation (GO:0030852) | 4.05154359 |
| 19 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.74003531 |
| 20 | positive thymic T cell selection (GO:0045059) | 3.73767986 |
| 21 | regulation of leukocyte degranulation (GO:0043300) | 3.67042768 |
| 22 | negative thymic T cell selection (GO:0045060) | 3.65292875 |
| 23 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.64997065 |
| 24 | regulation of mast cell degranulation (GO:0043304) | 3.62116458 |
| 25 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.55775518 |
| 26 | neutrophil mediated immunity (GO:0002446) | 3.55356465 |
| 27 | negative regulation of cell killing (GO:0031342) | 3.51436615 |
| 28 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.51436615 |
| 29 | negative regulation of interleukin-8 production (GO:0032717) | 3.40712811 |
| 30 | mature B cell differentiation involved in immune response (GO:0002313) | 3.38903978 |
| 31 | positive regulation by symbiont of host defense response (GO:0052509) | 3.38290674 |
| 32 | modulation by symbiont of host defense response (GO:0052031) | 3.38290674 |
| 33 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.38290674 |
| 34 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.38290674 |
| 35 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.38290674 |
| 36 | modulation by symbiont of host immune response (GO:0052553) | 3.38290674 |
| 37 | cell wall macromolecule catabolic process (GO:0016998) | 3.37942926 |
| 38 | megakaryocyte development (GO:0035855) | 3.36872263 |
| 39 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.36469679 |
| 40 | negative T cell selection (GO:0043383) | 3.34867874 |
| 41 | negative regulation of T cell mediated immunity (GO:0002710) | 3.31081026 |
| 42 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.27190752 |
| 43 | macrophage activation involved in immune response (GO:0002281) | 3.18924318 |
| 44 | germinal center formation (GO:0002467) | 3.18665966 |
| 45 | microglial cell activation (GO:0001774) | 3.17336153 |
| 46 | Peyers patch development (GO:0048541) | 3.15429516 |
| 47 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.15429516 |
| 48 | myeloid cell activation involved in immune response (GO:0002275) | 3.13836627 |
| 49 | T cell migration (GO:0072678) | 3.12124839 |
| 50 | regulation of regulated secretory pathway (GO:1903305) | 3.07800593 |
| 51 | histone H3-K36 demethylation (GO:0070544) | 3.05985270 |
| 52 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.05911500 |
| 53 | leukocyte degranulation (GO:0043299) | 3.05088081 |
| 54 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.04820541 |
| 55 | detection of other organism (GO:0098543) | 3.02007393 |
| 56 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.99097416 |
| 57 | regulation of erythrocyte differentiation (GO:0045646) | 2.98675779 |
| 58 | positive T cell selection (GO:0043368) | 2.97638095 |
| 59 | neutrophil activation (GO:0042119) | 2.94156926 |
| 60 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.93552217 |
| 61 | activated T cell proliferation (GO:0050798) | 2.93132498 |
| 62 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.93090096 |
| 63 | regulation of hypersensitivity (GO:0002883) | 2.91925987 |
| 64 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.90626208 |
| 65 | regulation of mast cell activation (GO:0033003) | 2.90110586 |
| 66 | detection of bacterium (GO:0016045) | 2.88658789 |
| 67 | T cell selection (GO:0045058) | 2.88216610 |
| 68 | negative regulation of interleukin-6 production (GO:0032715) | 2.87188293 |
| 69 | myeloid leukocyte mediated immunity (GO:0002444) | 2.84761070 |
| 70 | immunoglobulin mediated immune response (GO:0016064) | 2.83485436 |
| 71 | mature B cell differentiation (GO:0002335) | 2.80151778 |
| 72 | cell wall macromolecule metabolic process (GO:0044036) | 2.79506674 |
| 73 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.79037569 |
| 74 | response to protozoan (GO:0001562) | 2.78421192 |
| 75 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.77300087 |
| 76 | macrophage activation (GO:0042116) | 2.76753329 |
| 77 | cellular response to exogenous dsRNA (GO:0071360) | 2.74778571 |
| 78 | negative regulation of interleukin-12 production (GO:0032695) | 2.73577828 |
| 79 | positive regulation of mast cell degranulation (GO:0043306) | 2.73180932 |
| 80 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.73180932 |
| 81 | leukocyte aggregation (GO:0070486) | 2.70219336 |
| 82 | thymic T cell selection (GO:0045061) | 2.69743123 |
| 83 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.69585893 |
| 84 | regulation of female gonad development (GO:2000194) | 2.69201976 |
| 85 | histone H3-K4 trimethylation (GO:0080182) | 2.67699853 |
| 86 | positive regulation of alpha-beta T cell differentiation (GO:0046638) | 2.67071704 |
| 87 | positive regulation of mast cell activation (GO:0033005) | 2.67041895 |
| 88 | interkinetic nuclear migration (GO:0022027) | 2.66504192 |
| 89 | pinocytosis (GO:0006907) | 2.66346083 |
| 90 | B cell homeostasis (GO:0001782) | 2.66341024 |
| 91 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.66127401 |
| 92 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.65450175 |
| 93 | regulation of growth of symbiont in host (GO:0044126) | 2.65450175 |
| 94 | negative regulation of growth of symbiont in host (GO:0044130) | 2.65450175 |
| 95 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.65450175 |
| 96 | dosage compensation (GO:0007549) | 2.63165394 |
| 97 | negative regulation of bone resorption (GO:0045779) | 2.62226077 |
| 98 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.62142622 |
| 99 | histone H3-K9 modification (GO:0061647) | 2.61608422 |
| 100 | macrophage differentiation (GO:0030225) | 2.61239375 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.97389002 |
| 2 | VDR_21846776_ChIP-Seq_THP-1_Human | 4.50392448 |
| 3 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.07016423 |
| 4 | VDR_24763502_ChIP-Seq_THP-1_Human | 4.01822276 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.80015378 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.63372524 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.51511130 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.22617566 |
| 9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.86561651 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.86070317 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.81875547 |
| 12 | MYB_26560356_Chip-Seq_TH2_Human | 2.78256806 |
| 13 | MYC_22102868_ChIP-Seq_BL_Human | 2.70419563 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.64696995 |
| 15 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.61948365 |
| 16 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.47173652 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.46439721 |
| 18 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.39996437 |
| 19 | SPI1_23127762_ChIP-Seq_K562_Human | 2.37263035 |
| 20 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.34954181 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.34527245 |
| 22 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.33787607 |
| 23 | MYB_26560356_Chip-Seq_TH1_Human | 2.29703212 |
| 24 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.20163073 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.16315122 |
| 26 | UTX_26944678_Chip-Seq_JUKART_Human | 2.15783160 |
| 27 | MAF_26560356_Chip-Seq_TH1_Human | 2.13897711 |
| 28 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.11801927 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.06948936 |
| 30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.05604492 |
| 31 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.01367817 |
| 32 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.95452969 |
| 33 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.93862237 |
| 34 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.93025980 |
| 35 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.89350043 |
| 36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.88911518 |
| 37 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.88775318 |
| 38 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.84931315 |
| 39 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.83063860 |
| 40 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.77388799 |
| 41 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.71256204 |
| 42 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.70834738 |
| 43 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.67617551 |
| 44 | MAF_26560356_Chip-Seq_TH2_Human | 1.62130656 |
| 45 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.61876098 |
| 46 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.59219765 |
| 47 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55684763 |
| 48 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.55134648 |
| 49 | GATA1_19941826_ChIP-Seq_K562_Human | 1.54084594 |
| 50 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.52840454 |
| 51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.52414560 |
| 52 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.49091042 |
| 53 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45073312 |
| 54 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.43764747 |
| 55 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.43199894 |
| 56 | GATA1_22025678_ChIP-Seq_K562_Human | 1.40229438 |
| 57 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.40040326 |
| 58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.39275417 |
| 59 | GATA2_19941826_ChIP-Seq_K562_Human | 1.39018109 |
| 60 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.37074728 |
| 61 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.33547286 |
| 62 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.31305327 |
| 63 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.31083585 |
| 64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.28372774 |
| 65 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.28185663 |
| 66 | GATA3_26560356_Chip-Seq_TH2_Human | 1.27964254 |
| 67 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.27490248 |
| 68 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23377138 |
| 69 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.18710041 |
| 70 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.17149086 |
| 71 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.15404346 |
| 72 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13411976 |
| 73 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11865024 |
| 74 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.07978236 |
| 75 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07176214 |
| 76 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.06371084 |
| 77 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06023891 |
| 78 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.05220298 |
| 79 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.04831257 |
| 80 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.02025526 |
| 81 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01077601 |
| 82 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.99213931 |
| 83 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98262465 |
| 84 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.95522720 |
| 85 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95089065 |
| 86 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94996040 |
| 87 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.93854913 |
| 88 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90786492 |
| 89 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.90032818 |
| 90 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.89179225 |
| 91 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.89144260 |
| 92 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.82765112 |
| 93 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.81921645 |
| 94 | P300_27268052_Chip-Seq_Bcells_Human | 0.81471607 |
| 95 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.79434864 |
| 96 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.79356521 |
| 97 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.75684921 |
| 98 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.75624183 |
| 99 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.74885523 |
| 100 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.74349596 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002396_abnormal_hematopoietic_system | 3.97153795 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.59562440 |
| 3 | MP0003172_abnormal_lysosome_physiology | 3.30319048 |
| 4 | MP0003436_decreased_susceptibility_to | 3.01073296 |
| 5 | MP0003303_peritoneal_inflammation | 2.82444823 |
| 6 | MP0005464_abnormal_platelet_physiology | 2.80107383 |
| 7 | MP0002009_preneoplasia | 2.78692189 |
| 8 | MP0002419_abnormal_innate_immunity | 2.64261475 |
| 9 | MP0004808_abnormal_hematopoietic_stem | 2.63523204 |
| 10 | MP0003763_abnormal_thymus_physiology | 2.62936328 |
| 11 | MP0005397_hematopoietic_system_phenotyp | 2.60964356 |
| 12 | MP0001545_abnormal_hematopoietic_system | 2.60964356 |
| 13 | MP0009278_abnormal_bone_marrow | 2.55898769 |
| 14 | MP0003724_increased_susceptibility_to | 2.29103211 |
| 15 | MP0001800_abnormal_humoral_immune | 2.26923268 |
| 16 | MP0005025_abnormal_response_to | 2.22682107 |
| 17 | MP0005058_abnormal_lysosome_morphology | 2.19312751 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.09675174 |
| 19 | MP0001819_abnormal_immune_cell | 2.06147261 |
| 20 | MP0002723_abnormal_immune_serum | 2.00475590 |
| 21 | MP0005000_abnormal_immune_tolerance | 1.99778997 |
| 22 | MP0002398_abnormal_bone_marrow | 1.99049453 |
| 23 | MP0002166_altered_tumor_susceptibility | 1.95641404 |
| 24 | MP0003828_pulmonary_edema | 1.95364099 |
| 25 | MP0002452_abnormal_antigen_presenting | 1.92063734 |
| 26 | MP0003300_gastrointestinal_ulcer | 1.90422453 |
| 27 | MP0006082_CNS_inflammation | 1.82510559 |
| 28 | MP0000716_abnormal_immune_system | 1.74715803 |
| 29 | MP0002722_abnormal_immune_system | 1.72517503 |
| 30 | MP0000689_abnormal_spleen_morphology | 1.71038712 |
| 31 | MP0000685_abnormal_immune_system | 1.69862843 |
| 32 | MP0003656_abnormal_erythrocyte_physiolo | 1.68443547 |
| 33 | MP0002405_respiratory_system_inflammati | 1.66808184 |
| 34 | MP0000569_abnormal_digit_pigmentation | 1.65606768 |
| 35 | MP0000703_abnormal_thymus_morphology | 1.64779831 |
| 36 | MP0000465_gastrointestinal_hemorrhage | 1.61383757 |
| 37 | MP0001790_abnormal_immune_system | 1.57882911 |
| 38 | MP0005387_immune_system_phenotype | 1.57882911 |
| 39 | MP0005671_abnormal_response_to | 1.54640272 |
| 40 | MP0005666_abnormal_adipose_tissue | 1.54582465 |
| 41 | MP0002148_abnormal_hypersensitivity_rea | 1.48589128 |
| 42 | MP0008057_abnormal_DNA_replication | 1.47746774 |
| 43 | MP0001851_eye_inflammation | 1.45636060 |
| 44 | MP0002429_abnormal_blood_cell | 1.45498648 |
| 45 | MP0010155_abnormal_intestine_physiology | 1.44693713 |
| 46 | MP0009785_altered_susceptibility_to | 1.43027496 |
| 47 | MP0004130_abnormal_muscle_cell | 1.38699762 |
| 48 | MP0004185_abnormal_adipocyte_glucose | 1.35923240 |
| 49 | MP0001533_abnormal_skeleton_physiology | 1.31354473 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.29650479 |
| 51 | MP0000015_abnormal_ear_pigmentation | 1.27975599 |
| 52 | MP0004947_skin_inflammation | 1.23965618 |
| 53 | MP0002132_abnormal_respiratory_system | 1.23934021 |
| 54 | MP0001845_abnormal_inflammatory_respons | 1.23418911 |
| 55 | MP0001853_heart_inflammation | 1.20987645 |
| 56 | MP0005174_abnormal_tail_pigmentation | 1.19986223 |
| 57 | MP0005075_abnormal_melanosome_morpholog | 1.18678831 |
| 58 | MP0003866_abnormal_defecation | 1.18117850 |
| 59 | MP0002006_tumorigenesis | 1.10899400 |
| 60 | MP0003191_abnormal_cellular_cholesterol | 1.10048176 |
| 61 | MP0009333_abnormal_splenocyte_physiolog | 1.08828615 |
| 62 | MP0005410_abnormal_fertilization | 1.08552355 |
| 63 | MP0002998_abnormal_bone_remodeling | 1.07632112 |
| 64 | MP0008469_abnormal_protein_level | 1.07389551 |
| 65 | MP0001986_abnormal_taste_sensitivity | 1.06157774 |
| 66 | MP0000681_abnormal_thyroid_gland | 1.04493274 |
| 67 | MP0004381_abnormal_hair_follicle | 1.00681287 |
| 68 | MP0005670_abnormal_white_adipose | 0.99190785 |
| 69 | MP0009115_abnormal_fat_cell | 0.95307121 |
| 70 | MP0004484_altered_response_of | 0.95237183 |
| 71 | MP0008004_abnormal_stomach_pH | 0.94512835 |
| 72 | MP0002971_abnormal_brown_adipose | 0.92729193 |
| 73 | MP0005535_abnormal_body_temperature | 0.91878809 |
| 74 | MP0005375_adipose_tissue_phenotype | 0.88330373 |
| 75 | MP0005409_darkened_coat_color | 0.82291122 |
| 76 | MP0009764_decreased_sensitivity_to | 0.82239881 |
| 77 | MP0005076_abnormal_cell_differentiation | 0.79385741 |
| 78 | MP0000604_amyloidosis | 0.78468618 |
| 79 | MP0003045_fibrosis | 0.77672873 |
| 80 | MP0003690_abnormal_glial_cell | 0.77018180 |
| 81 | MP0001765_abnormal_ion_homeostasis | 0.76397895 |
| 82 | MP0005220_abnormal_exocrine_pancreas | 0.75956808 |
| 83 | MP0008961_abnormal_basal_metabolism | 0.75625880 |
| 84 | MP0004883_abnormal_blood_vessel | 0.74907666 |
| 85 | MP0000249_abnormal_blood_vessel | 0.74398130 |
| 86 | MP0005166_decreased_susceptibility_to | 0.74227223 |
| 87 | MP0008007_abnormal_cellular_replicative | 0.73817307 |
| 88 | MP0005164_abnormal_response_to | 0.72098092 |
| 89 | MP0002933_joint_inflammation | 0.71079195 |
| 90 | MP0005334_abnormal_fat_pad | 0.70548859 |
| 91 | MP0001873_stomach_inflammation | 0.69991964 |
| 92 | MP0004036_abnormal_muscle_relaxation | 0.67637592 |
| 93 | MP0002019_abnormal_tumor_incidence | 0.66808356 |
| 94 | MP0005310_abnormal_salivary_gland | 0.65588338 |
| 95 | MP0005451_abnormal_body_composition | 0.63729424 |
| 96 | MP0008260_abnormal_autophagy | 0.61870139 |
| 97 | MP0002138_abnormal_hepatobiliary_system | 0.60651324 |
| 98 | MP0009763_increased_sensitivity_to | 0.59806362 |
| 99 | MP0005390_skeleton_phenotype | 0.59514134 |
| 100 | MP0010307_abnormal_tumor_latency | 0.59218133 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute lymphatic leukemia (HP:0006721) | 5.11008201 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.40069501 |
| 3 | Acute myeloid leukemia (HP:0004808) | 4.39798630 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 4.13978100 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.12869292 |
| 6 | Prolonged bleeding time (HP:0003010) | 4.09521978 |
| 7 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.86494919 |
| 8 | Recurrent cutaneous fungal infections (HP:0011370) | 3.78591031 |
| 9 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.78591031 |
| 10 | Myositis (HP:0100614) | 3.71610958 |
| 11 | Recurrent fungal infections (HP:0002841) | 3.69873130 |
| 12 | Thrombocytosis (HP:0001894) | 3.60753259 |
| 13 | Panhypogammaglobulinemia (HP:0003139) | 3.51015298 |
| 14 | Eczematoid dermatitis (HP:0000976) | 3.41517498 |
| 15 | Stomatitis (HP:0010280) | 3.38315169 |
| 16 | Recurrent viral infections (HP:0004429) | 3.28336177 |
| 17 | Epistaxis (HP:0000421) | 3.24313953 |
| 18 | Recurrent skin infections (HP:0001581) | 3.23128374 |
| 19 | Spontaneous hematomas (HP:0007420) | 3.22369700 |
| 20 | Agammaglobulinemia (HP:0004432) | 3.16894021 |
| 21 | Meningitis (HP:0001287) | 3.16163640 |
| 22 | Inflammation of the large intestine (HP:0002037) | 3.12535022 |
| 23 | Abnormality of B cell number (HP:0010975) | 3.10444574 |
| 24 | Increased IgE level (HP:0003212) | 3.04984853 |
| 25 | Granulocytopenia (HP:0001913) | 3.04631554 |
| 26 | Colitis (HP:0002583) | 3.03746159 |
| 27 | Gastrointestinal inflammation (HP:0004386) | 3.03618631 |
| 28 | Spondylolisthesis (HP:0003302) | 3.00077944 |
| 29 | B lymphocytopenia (HP:0010976) | 2.97605129 |
| 30 | Chest pain (HP:0100749) | 2.97043269 |
| 31 | Gingival bleeding (HP:0000225) | 2.92353950 |
| 32 | Papilledema (HP:0001085) | 2.91339534 |
| 33 | Chronic obstructive pulmonary disease (HP:0006510) | 2.90702593 |
| 34 | Obstructive lung disease (HP:0006536) | 2.90702593 |
| 35 | Gastrointestinal infarctions (HP:0005244) | 2.85376885 |
| 36 | Abnormality of T cell physiology (HP:0011840) | 2.80065309 |
| 37 | Gingivitis (HP:0000230) | 2.74124352 |
| 38 | Dysostosis multiplex (HP:0000943) | 2.73672066 |
| 39 | Cellulitis (HP:0100658) | 2.72316376 |
| 40 | Abnormality of macrophages (HP:0004311) | 2.71563187 |
| 41 | Encephalitis (HP:0002383) | 2.68778053 |
| 42 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.61781574 |
| 43 | Thoracic kyphosis (HP:0002942) | 2.61599475 |
| 44 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.60176823 |
| 45 | Amyloidosis (HP:0011034) | 2.58940608 |
| 46 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.58842555 |
| 47 | Mediastinal lymphadenopathy (HP:0100721) | 2.58098365 |
| 48 | Abnormality of the fingertips (HP:0001211) | 2.54833055 |
| 49 | Increased cerebral lipofuscin (HP:0011813) | 2.43027584 |
| 50 | Petechiae (HP:0000967) | 2.41693703 |
| 51 | Abnormality of T cells (HP:0002843) | 2.41259295 |
| 52 | Arterial thrombosis (HP:0004420) | 2.40045372 |
| 53 | Abnormality of the prostate (HP:0008775) | 2.39873039 |
| 54 | Vasculitis (HP:0002633) | 2.39613944 |
| 55 | Orchitis (HP:0100796) | 2.37328411 |
| 56 | Hemoptysis (HP:0002105) | 2.36445494 |
| 57 | Autoimmune thrombocytopenia (HP:0001973) | 2.35732802 |
| 58 | Fatigue (HP:0012378) | 2.31720263 |
| 59 | Leukocytosis (HP:0001974) | 2.30284131 |
| 60 | Viral hepatitis (HP:0006562) | 2.26264906 |
| 61 | Autoimmune hemolytic anemia (HP:0001890) | 2.23910845 |
| 62 | Abnormal platelet function (HP:0011869) | 2.21979304 |
| 63 | Impaired platelet aggregation (HP:0003540) | 2.21979304 |
| 64 | Retrobulbar optic neuritis (HP:0100654) | 2.20808689 |
| 65 | Optic neuritis (HP:0100653) | 2.20808689 |
| 66 | Osteomyelitis (HP:0002754) | 2.18670257 |
| 67 | Polygenic inheritance (HP:0010982) | 2.18590653 |
| 68 | Asymmetric septal hypertrophy (HP:0001670) | 2.15772804 |
| 69 | Pustule (HP:0200039) | 2.11989475 |
| 70 | Abnormality of the thoracic spine (HP:0100711) | 2.11514007 |
| 71 | Thickened calvaria (HP:0002684) | 2.08230293 |
| 72 | Episodic fever (HP:0001954) | 2.07458075 |
| 73 | Hypochromic anemia (HP:0001931) | 2.06031937 |
| 74 | Pulmonary embolism (HP:0002204) | 2.05349675 |
| 75 | Abnormality of the lumbar spine (HP:0100712) | 1.93885616 |
| 76 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.93721457 |
| 77 | T lymphocytopenia (HP:0005403) | 1.90836956 |
| 78 | Urticaria (HP:0001025) | 1.88110259 |
| 79 | Pulmonary infiltrates (HP:0002113) | 1.87732332 |
| 80 | Keratoconjunctivitis sicca (HP:0001097) | 1.87091146 |
| 81 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.86897558 |
| 82 | Eosinophilia (HP:0001880) | 1.85468623 |
| 83 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.85035764 |
| 84 | Severe combined immunodeficiency (HP:0004430) | 1.84535178 |
| 85 | Mucopolysacchariduria (HP:0008155) | 1.84418473 |
| 86 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.84418473 |
| 87 | Abnormality of T cell number (HP:0011839) | 1.83861305 |
| 88 | Severe visual impairment (HP:0001141) | 1.82923755 |
| 89 | Interstitial pulmonary disease (HP:0006530) | 1.81364366 |
| 90 | Neurodegeneration (HP:0002180) | 1.81246637 |
| 91 | Periodontitis (HP:0000704) | 1.79602793 |
| 92 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.79232925 |
| 93 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.79232925 |
| 94 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.79232925 |
| 95 | Ocular albinism (HP:0001107) | 1.78363307 |
| 96 | Hypoplasia of the thymus (HP:0000778) | 1.77682542 |
| 97 | Hypochromic microcytic anemia (HP:0004840) | 1.75462715 |
| 98 | Dysmetric saccades (HP:0000641) | 1.74945641 |
| 99 | Syringomyelia (HP:0003396) | 1.73624963 |
| 100 | Spinal cord lesions (HP:0100561) | 1.73624963 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 3.78349220 |
| 2 | KIT | 3.39678853 |
| 3 | FES | 2.97572085 |
| 4 | PRPF4B | 2.67538830 |
| 5 | TEC | 2.56309262 |
| 6 | MAP3K13 | 2.50603479 |
| 7 | MAP2K3 | 2.48623629 |
| 8 | FLT3 | 2.40803143 |
| 9 | MAP4K1 | 2.36646349 |
| 10 | BTK | 2.26098302 |
| 11 | MAP3K14 | 2.15711961 |
| 12 | TAOK3 | 2.13311545 |
| 13 | ZAP70 | 2.02870549 |
| 14 | EEF2K | 2.00673164 |
| 15 | SYK | 1.96754742 |
| 16 | TNK2 | 1.95386890 |
| 17 | PIK3CG | 1.77998280 |
| 18 | BLK | 1.75451920 |
| 19 | CDK12 | 1.74634046 |
| 20 | CSF1R | 1.72872038 |
| 21 | ITK | 1.70147236 |
| 22 | TYK2 | 1.68117270 |
| 23 | TRIB3 | 1.66135452 |
| 24 | CDK6 | 1.62523195 |
| 25 | GRK6 | 1.57035996 |
| 26 | MAP3K6 | 1.49092026 |
| 27 | TRPM7 | 1.48172899 |
| 28 | TBK1 | 1.43702162 |
| 29 | BRD4 | 1.40507551 |
| 30 | TXK | 1.40439344 |
| 31 | HCK | 1.39228108 |
| 32 | ERN1 | 1.34663177 |
| 33 | JAK3 | 1.27543614 |
| 34 | BMPR2 | 1.21873481 |
| 35 | MAP3K7 | 1.20024495 |
| 36 | MAPK12 | 1.18121549 |
| 37 | LYN | 1.18002061 |
| 38 | JAK1 | 1.11631728 |
| 39 | PKN2 | 1.11258252 |
| 40 | MAPK7 | 1.05260625 |
| 41 | LCK | 1.04583240 |
| 42 | PDK1 | 1.02909607 |
| 43 | IKBKE | 1.01285104 |
| 44 | IRAK4 | 1.00544076 |
| 45 | HIPK2 | 0.99654876 |
| 46 | JAK2 | 0.98801675 |
| 47 | CDK4 | 0.98461952 |
| 48 | CSK | 0.94620346 |
| 49 | IKBKB | 0.93956804 |
| 50 | MAP2K6 | 0.92793505 |
| 51 | MARK2 | 0.90442880 |
| 52 | PDPK1 | 0.87120095 |
| 53 | MAP3K1 | 0.84625708 |
| 54 | MARK3 | 0.74016740 |
| 55 | RPS6KB2 | 0.72522255 |
| 56 | NEK9 | 0.72077487 |
| 57 | RET | 0.72055538 |
| 58 | MAPK15 | 0.70936747 |
| 59 | MAP2K2 | 0.70632296 |
| 60 | PRKCQ | 0.70374222 |
| 61 | FGFR3 | 0.69979753 |
| 62 | MATK | 0.68546580 |
| 63 | MAPK11 | 0.68244955 |
| 64 | RPS6KC1 | 0.68099171 |
| 65 | RPS6KL1 | 0.68099171 |
| 66 | TTN | 0.65721936 |
| 67 | WNK1 | 0.62280581 |
| 68 | CAMK1G | 0.62209440 |
| 69 | CDK3 | 0.61348036 |
| 70 | RPS6KA6 | 0.60544639 |
| 71 | PRKAA2 | 0.60360052 |
| 72 | PLK4 | 0.59923593 |
| 73 | FRK | 0.59009699 |
| 74 | RPS6KA4 | 0.58004165 |
| 75 | KSR2 | 0.57764630 |
| 76 | MAPK4 | 0.54863001 |
| 77 | YES1 | 0.54760300 |
| 78 | MAPK3 | 0.49379588 |
| 79 | SIK2 | 0.46466889 |
| 80 | PASK | 0.44264015 |
| 81 | PIM1 | 0.41466460 |
| 82 | IRAK1 | 0.41223056 |
| 83 | MAP2K4 | 0.40328592 |
| 84 | DAPK2 | 0.38516004 |
| 85 | STK11 | 0.37844443 |
| 86 | CAMK1D | 0.37804397 |
| 87 | STK10 | 0.36916190 |
| 88 | MTOR | 0.36738709 |
| 89 | RPS6KA2 | 0.35998524 |
| 90 | LRRK2 | 0.34233822 |
| 91 | TGFBR2 | 0.33521442 |
| 92 | MAP3K2 | 0.32717486 |
| 93 | MOS | 0.32110703 |
| 94 | ABL1 | 0.31931740 |
| 95 | MAPK1 | 0.31360084 |
| 96 | SGK1 | 0.30956723 |
| 97 | FYN | 0.28880271 |
| 98 | IRAK2 | 0.28660549 |
| 99 | SGK3 | 0.28486915 |
| 100 | RPS6KA1 | 0.26688119 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.92841094 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.59991083 |
| 3 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.57081237 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.43064968 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.20359278 |
| 6 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 2.05102443 |
| 7 | Platelet activation_Homo sapiens_hsa04611 | 1.75539203 |
| 8 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.69998498 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.69686935 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.67997872 |
| 11 | Asthma_Homo sapiens_hsa05310 | 1.66538977 |
| 12 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.63341452 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 1.61689241 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.59488258 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.58938600 |
| 16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.58365921 |
| 17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.52029102 |
| 18 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.49126872 |
| 19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.46753768 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.45149468 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 1.44002399 |
| 22 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.42146801 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.41639161 |
| 24 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.41271252 |
| 25 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.40395513 |
| 26 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.37827343 |
| 27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.36695694 |
| 28 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.31311904 |
| 29 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.29797827 |
| 30 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.29765829 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.27587299 |
| 32 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.26737562 |
| 33 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.24032060 |
| 34 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.19878711 |
| 35 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.16234727 |
| 36 | Measles_Homo sapiens_hsa05162 | 1.14488196 |
| 37 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.14038038 |
| 38 | Hepatitis B_Homo sapiens_hsa05161 | 1.11714745 |
| 39 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.11392698 |
| 40 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.09764042 |
| 41 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.09515202 |
| 42 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.09033013 |
| 43 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.05417629 |
| 44 | Malaria_Homo sapiens_hsa05144 | 1.05270996 |
| 45 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.03951643 |
| 46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.03794789 |
| 47 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.01873180 |
| 48 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.00255681 |
| 49 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.00226278 |
| 50 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.99947401 |
| 51 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.97644883 |
| 52 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.97219080 |
| 53 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.95848789 |
| 54 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.95377315 |
| 55 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.95040240 |
| 56 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.92544300 |
| 57 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.90566772 |
| 58 | Insulin resistance_Homo sapiens_hsa04931 | 0.90556087 |
| 59 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.88290014 |
| 60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88279127 |
| 61 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.86951974 |
| 62 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.86244543 |
| 63 | Legionellosis_Homo sapiens_hsa05134 | 0.84412288 |
| 64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.84408129 |
| 65 | Viral myocarditis_Homo sapiens_hsa05416 | 0.81029658 |
| 66 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.78548491 |
| 67 | Renin secretion_Homo sapiens_hsa04924 | 0.76533561 |
| 68 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.73351745 |
| 69 | Long-term potentiation_Homo sapiens_hsa04720 | 0.73012622 |
| 70 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.70216698 |
| 71 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.69842711 |
| 72 | Pertussis_Homo sapiens_hsa05133 | 0.69107135 |
| 73 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68654061 |
| 74 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.65840628 |
| 75 | Amoebiasis_Homo sapiens_hsa05146 | 0.65672960 |
| 76 | Lysosome_Homo sapiens_hsa04142 | 0.65149128 |
| 77 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.63595322 |
| 78 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63370671 |
| 79 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.63261063 |
| 80 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.62856715 |
| 81 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62694514 |
| 82 | Hepatitis C_Homo sapiens_hsa05160 | 0.62474685 |
| 83 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.60540268 |
| 84 | Salivary secretion_Homo sapiens_hsa04970 | 0.59488407 |
| 85 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.59244763 |
| 86 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.56001134 |
| 87 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.55697391 |
| 88 | HTLV-I infection_Homo sapiens_hsa05166 | 0.54264180 |
| 89 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.54061775 |
| 90 | Glioma_Homo sapiens_hsa05214 | 0.52689282 |
| 91 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.52629014 |
| 92 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.50088775 |
| 93 | Colorectal cancer_Homo sapiens_hsa05210 | 0.48561938 |
| 94 | Lysine degradation_Homo sapiens_hsa00310 | 0.48301284 |
| 95 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.46151290 |
| 96 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.46038773 |
| 97 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.45606261 |
| 98 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.45214290 |
| 99 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44439632 |
| 100 | Apoptosis_Homo sapiens_hsa04210 | 0.42813941 |

